China Biologic Products Holdings Inc.

119.99+1.98+1.68%Vol 390.04K1Y Perf 10.57%
Apr 20th, 2021 16:00 DELAYED
BID119.98 ASK119.99
Open118.01 Previous Close118.01
Pre-Market- After-Market120.04
 - -  0.05 0.04%
Target Price
103.00 
Analyst Rating
Hold 3.00
Potential %
-14.16 
Finscreener Ranking
★★★★     55.30
Insiders Trans % 3/6/12 mo.
-/-/- 
Value Ranking
★★★★★     62.96
Insiders Value % 3/6/12 mo.
-/-/- 
Growth Ranking
★★★★★     72.70
Insiders Shares Cnt. % 3/6/12 mo.
-/-/- 
Income Ranking
 —    -
Market Cap4.72B 
Earnings Rating
Buy
Price Range Ratio 52W %
99.70 
Earnings Date
19th May 2021

Today's Price Range

117.27120.05

52W Range

99.74120.05

5 Year PE Ratio Range

19.3045.00

Summary:

Neutral

Technical Indicators: Neutral
Moving Averages: Sell
Performance
1 Week
1.43%
1 Month
1.82%
3 Months
1.26%
6 Months
5.77%
1 Year
10.57%
3 Years
39.96%
5 Years
-5.50%
10 Years
699.93%

TickerPriceChg.Chg.%
CBPO119.991.98001.68
AAPL133.11-1.7300-1.28
GOOG2 293.63-8.7700-0.38
MSFT258.26-0.4800-0.19
XOM55.29-1.1900-2.11
WFC42.54-1.3400-3.05
JNJ166.483.79002.33
FB302.650.41000.14
GE13.06-0.4000-2.97
JPM149.27-3.3800-2.21
Financial StrengthValueIndustryS&P 500US Markets
9.70
11.80
-
0.00
661.50
Leverage Ratio 1.10
ProfitabilityValueIndustryS&P 500US Markets
65.70
38.60
43.90
39.80
31.77
RevenueValueIndustryS&P 500US Markets
361.78M
9.33
10.00
12.11
Earnings HistoryEstimateReportedSurprise %
Q04 2020-0.64-
Q03 20201.091.04-4.59
Q02 20201.080.95-12.04
Q01 20201.191.4017.65
Q04 2019-0.53-
Q03 20190.711.4097.18
Q02 20191.031.2420.39
Q01 20190.991.1112.12
Earnings Per EndEstimateRevision %Trend
12/2020 QR0.500.00-
12/2020 FY3.880.00-
3/2021 QR1.150.00-
12/2021 FY4.300.00-
Next Report Date19th May 2021
Estimated EPS Next Report-
Estimates Count-
EPS Growth Next 5 Years %-
Volume Overview
Volume390.04K
Shares Outstanding39.36M
Trades Count2.43K
Dollar Volume13.31M
Avg. Volume147.69K
Avg. Weekly Volume163.00K
Avg. Monthly Volume109.33K
Avg. Quarterly Volume161.07K

China Biologic Products Holdings Inc. (NASDAQ: CBPO) stock closed at 119.99 per share at the end of the most recent trading day (a 1.68% change compared to the prior day closing price) with a volume of 390.92K shares and market capitalization of 4.72B. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Biotechnology industry, Healthcare sector and employs 2269 people. China Biologic Products Holdings Inc. CEO is Joseph Chow.

The one-year performance of China Biologic Products Holdings Inc. stock is 10.57%, while year-to-date (YTD) performance is 1.59%. CBPO stock has a five-year performance of -5.5%. Its 52-week range is between 99.74 and 120.05, which gives CBPO stock a 52-week price range ratio of 99.70%

China Biologic Products Holdings Inc. currently has a PE ratio of 30.70, a price-to-book (PB) ratio of 2.31, a price-to-sale (PS) ratio of 12.65, a price to cashflow ratio of 18.10, a PEG ratio of 2.32, a ROA of 6.97%, a ROC of 7.43% and a ROE of 7.95%. The company’s profit margin is 31.77%, its EBITDA margin is 43.90%, and its revenue ttm is $361.78 Million , which makes it $9.33 revenue per share.

Of the last four earnings reports from China Biologic Products Holdings Inc., there were 1 positive earnings surprise and 2 negative earnings surprise. The company has EPS estimate of $0.00 for the next earnings report. China Biologic Products Holdings Inc.’s next earnings report date is 19th May 2021.

The consensus rating of Wall Street analysts for China Biologic Products Holdings Inc. is Hold (3), with a target price of $103, which is -14.16% compared to the current price. The earnings rating for China Biologic Products Holdings Inc. stock is Buy (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

China Biologic Products Holdings Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

China Biologic Products Holdings Inc. has a Neutral technical analysis rating based on Technical Indicators (ADX : 5.19, ATR14 : 1.30, CCI20 : 34.74, Chaikin Money Flow : 0.08, MACD : -0.19, Money Flow Index : 62.20, ROC : -0.34, RSI : 33.49, STOCH (14,3) : 48.85, STOCH RSI : 0.49, UO : 45.00, Williams %R : -51.15), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of China Biologic Products Holdings Inc. in the last 12-months were:

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
0 (0.00 %)
0 (0.00 %)
0
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0
Hold
1 (100.00 %)
1 (100.00 %)
0
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0
Strong Sell
0 (0.00 %)
0 (0.00 %)
0
Summary RatingHold
3.00
Hold
3.00
-

China Biologic Products Holdings Inc.

China Biologic Products Holdings Inc is a biopharmaceutical company principally engaged in the research, development, manufacturing and sales of human plasma-based products in China. The company operates its business through two majority owned subsidiaries, Shandong Taibang and Guizhou Taibang. China Biologic's product pipeline includes a variety of dosages across multiple product categories. Its principal products are human albumin and immunoglobulin for intravenous injection. All of the company's products are prescription medicines administered in the form of injections. China Biologic's sales model focuses on direct sales to hospitals and inoculation centers and is complemented by distributor sales.

CEO: Joseph Chow

Telephone: +86 1065983111

Address: 19 Chaoyang Park Road, Beijing 100125, , CN

Number of employees: 2 269

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

38%62%

Bearish Bullish

58%42%

Bearish Bullish

46%54%

News

Stocktwits